Kiwi cannabis firm Rua Bioscience appoints new CEO
Medicinal cannabis company Rua Bioscience (previously Hikurangi Cannabis) has appointed Rob Mitchell as its new chief executive officer.
Mitchell replaces co-founder Manu Caddie, who will move on to lead the regulatory and research divisions of the company.
Rua Bioscience chair Trevor Burt said the company started its search for a new CEO in 2019 to ensure it was best positioned to commercialise the business once regulations were in place.
The appointment of Mitchell gives the company, which started as a community project, much greater corporate clout.
Mitchell has spent the past 30 years in leadership roles for pharmaceutical multinationals, spending most of his career with Roche, eventually heading global product strategy for a division of the $88 billion Swiss company.
Despite his corporate leaning, Mitchell has made a commitment to the social mission that has always underpinned the business.
“I’m confident that the commercial success of this company will enable the founding vision to be realised,” he said.
Caddie said the time was right to hand the business on to a new leader and that he was looking forward to taking on the new role as “Kaihautu”.